EP2870261

BIOMARKERS ASSOCIATED WITH CDK INHIBITORS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    26.6.2013
  • EP published:
    6.12.2017
  • EP application number:
    13735529.3
  • Max expiry date:
    25.6.2033
  • Title:
    BIOMARKERS ASSOCIATED WITH CDK INHIBITORS

Timeline

Today
26.6.2013EP application
6.12.2017EP Publication

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056, Basel, CH
  • Name:
    Dana-Farber Cancer Institute, Inc.
  • Address:
    450 Brookline Avenue, 02215-5450, Boston, MA, US
  • Name:
    Broad Institute
  • Address:
    44 Binney Street, 02115, Boston, Massachusetts, US

Inventor

  • Name:
    CAPONIGRO, Giordano
  • Address:
    Cambridge, MA, US
  • Name:
    DELACH, Scott
  • Address:
    Cambridge, MA, US
  • Name:
    GARRAWAY, Levi
  • Address:
    Boston, MA, US
  • Name:
    JAGANI, Zainab
  • Address:
    Cambridge, MA, US
  • Name:
    KIM, Sunkyu
  • Address:
    Cambridge, MA, US
  • Name:
    KRYUKOV, Gregory
  • Address:
    Cambridge, MA, US

Priority

  • Number:
    201261669534 P
  • Date:
    9.7.2012
  • Country:
    US

Classification

  • Categories:
    C12Q 1/68

Upload documents